Because survivin-null embryos die at an early embryonic stage, the role of survivin in thymocyte development is unknown. We have investigated the role by deleting the survivin gene only in the T lineage and show here that loss of survivin blocks the transition from CD4− CD8− double negative (DN) thymocytes to CD4+ CD8+ double positive cells. Although the pre–T cell receptor signaling pathway is intact in survivin-deficient thymocytes, the cells cannot respond to its signals. In response to proliferative stimuli, cycling survivin-deficient DN cells exhibit cell cycle arrest, a spindle formation defect, and increased cell death. Strikingly, loss of survivin activates the tumor suppressor p53. However, the developmental defects caused by survivin deficiency cannot be rescued by p53 inactivation or introduction of Bcl-2. These lines of evidence indicate that developing thymocytes depend on the cytoprotective function of survivin and that this function is tightly coupled to cell proliferation but independent of p53 and Bcl-2. Thus, survivin plays a critical role in early thymocyte development.
Skip Nav Destination
Article navigation
2 February 2004
Article Contents
Article|
February 02 2004
Survivin Loss in Thymocytes Triggers p53-mediated Growth Arrest and p53-independent Cell Death
Hitoshi Okada,
Hitoshi Okada
1Advanced Medical Discovery Institute, University of Toronto, Toronto, Ontario M5G 2C1, Canada
2Ontario Cancer Institute, University of Toronto, Toronto, Ontario M5G 2C1, Canada
Search for other works by this author on:
Chris Bakal,
Chris Bakal
2Ontario Cancer Institute, University of Toronto, Toronto, Ontario M5G 2C1, Canada
4Department of Immunology, University of Toronto, Toronto, Ontario M5G 2C1, Canada
Search for other works by this author on:
Arda Shahinian,
Arda Shahinian
1Advanced Medical Discovery Institute, University of Toronto, Toronto, Ontario M5G 2C1, Canada
2Ontario Cancer Institute, University of Toronto, Toronto, Ontario M5G 2C1, Canada
Search for other works by this author on:
Andrew Elia,
Andrew Elia
1Advanced Medical Discovery Institute, University of Toronto, Toronto, Ontario M5G 2C1, Canada
2Ontario Cancer Institute, University of Toronto, Toronto, Ontario M5G 2C1, Canada
Search for other works by this author on:
Andrew Wakeham,
Andrew Wakeham
1Advanced Medical Discovery Institute, University of Toronto, Toronto, Ontario M5G 2C1, Canada
2Ontario Cancer Institute, University of Toronto, Toronto, Ontario M5G 2C1, Canada
Search for other works by this author on:
Woong-Kyung Suh,
Woong-Kyung Suh
1Advanced Medical Discovery Institute, University of Toronto, Toronto, Ontario M5G 2C1, Canada
2Ontario Cancer Institute, University of Toronto, Toronto, Ontario M5G 2C1, Canada
Search for other works by this author on:
Gordon S. Duncan,
Gordon S. Duncan
1Advanced Medical Discovery Institute, University of Toronto, Toronto, Ontario M5G 2C1, Canada
2Ontario Cancer Institute, University of Toronto, Toronto, Ontario M5G 2C1, Canada
Search for other works by this author on:
Maria Ciofani,
Maria Ciofani
4Department of Immunology, University of Toronto, Toronto, Ontario M5G 2C1, Canada
5Sunnybrook and Women's College Health Sciences Center, Toronto, Ontario M4N 3M5, Canada
Search for other works by this author on:
Robert Rottapel,
Robert Rottapel
2Ontario Cancer Institute, University of Toronto, Toronto, Ontario M5G 2C1, Canada
4Department of Immunology, University of Toronto, Toronto, Ontario M5G 2C1, Canada
Search for other works by this author on:
Juan Carlos Zúñiga-Pflücker,
Juan Carlos Zúñiga-Pflücker
4Department of Immunology, University of Toronto, Toronto, Ontario M5G 2C1, Canada
5Sunnybrook and Women's College Health Sciences Center, Toronto, Ontario M4N 3M5, Canada
Search for other works by this author on:
Tak W. Mak
Tak W. Mak
1Advanced Medical Discovery Institute, University of Toronto, Toronto, Ontario M5G 2C1, Canada
2Ontario Cancer Institute, University of Toronto, Toronto, Ontario M5G 2C1, Canada
3Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5G 2C1, Canada
4Department of Immunology, University of Toronto, Toronto, Ontario M5G 2C1, Canada
Search for other works by this author on:
Hitoshi Okada
1Advanced Medical Discovery Institute, University of Toronto, Toronto, Ontario M5G 2C1, Canada
2Ontario Cancer Institute, University of Toronto, Toronto, Ontario M5G 2C1, Canada
Chris Bakal
2Ontario Cancer Institute, University of Toronto, Toronto, Ontario M5G 2C1, Canada
4Department of Immunology, University of Toronto, Toronto, Ontario M5G 2C1, Canada
Arda Shahinian
1Advanced Medical Discovery Institute, University of Toronto, Toronto, Ontario M5G 2C1, Canada
2Ontario Cancer Institute, University of Toronto, Toronto, Ontario M5G 2C1, Canada
Andrew Elia
1Advanced Medical Discovery Institute, University of Toronto, Toronto, Ontario M5G 2C1, Canada
2Ontario Cancer Institute, University of Toronto, Toronto, Ontario M5G 2C1, Canada
Andrew Wakeham
1Advanced Medical Discovery Institute, University of Toronto, Toronto, Ontario M5G 2C1, Canada
2Ontario Cancer Institute, University of Toronto, Toronto, Ontario M5G 2C1, Canada
Woong-Kyung Suh
1Advanced Medical Discovery Institute, University of Toronto, Toronto, Ontario M5G 2C1, Canada
2Ontario Cancer Institute, University of Toronto, Toronto, Ontario M5G 2C1, Canada
Gordon S. Duncan
1Advanced Medical Discovery Institute, University of Toronto, Toronto, Ontario M5G 2C1, Canada
2Ontario Cancer Institute, University of Toronto, Toronto, Ontario M5G 2C1, Canada
Maria Ciofani
4Department of Immunology, University of Toronto, Toronto, Ontario M5G 2C1, Canada
5Sunnybrook and Women's College Health Sciences Center, Toronto, Ontario M4N 3M5, Canada
Robert Rottapel
2Ontario Cancer Institute, University of Toronto, Toronto, Ontario M5G 2C1, Canada
4Department of Immunology, University of Toronto, Toronto, Ontario M5G 2C1, Canada
Juan Carlos Zúñiga-Pflücker
4Department of Immunology, University of Toronto, Toronto, Ontario M5G 2C1, Canada
5Sunnybrook and Women's College Health Sciences Center, Toronto, Ontario M4N 3M5, Canada
Tak W. Mak
1Advanced Medical Discovery Institute, University of Toronto, Toronto, Ontario M5G 2C1, Canada
2Ontario Cancer Institute, University of Toronto, Toronto, Ontario M5G 2C1, Canada
3Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5G 2C1, Canada
4Department of Immunology, University of Toronto, Toronto, Ontario M5G 2C1, Canada
Address correspondence to Tak W. Mak, Advanced Medical Discovery Institute, 620 University Avenue, Suite 706, Toronto, Ontario M5G 2C1, Canada. Phone: (416) 946-2234; Fax: (416) 204-5300; email: [email protected]; or Hitoshi Okada, Advanced Medical Discovery Institute, 620 University Avenue, Suite 706, Toronto, Ontario M5G 2C1, Canada. Phone: (416) 946-4501; Fax: (416) 204-2278; email: [email protected]
C. Bakal and A. Shahinian contributed equally to this work.
Abbreviations used in this paper: 7AAD, 7-amino actinomycin D; DN, double negative; DP, double positive; ERK, extracellular signal–regulated kinase; ES, embryonic stem; HSA, heat stable antigen; Lin, lineage marker; SP, single positive.
Received:
December 03 2003
Accepted:
December 18 2003
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2004
J Exp Med (2004) 199 (3): 399–410.
Article history
Received:
December 03 2003
Accepted:
December 18 2003
Citation
Hitoshi Okada, Chris Bakal, Arda Shahinian, Andrew Elia, Andrew Wakeham, Woong-Kyung Suh, Gordon S. Duncan, Maria Ciofani, Robert Rottapel, Juan Carlos Zúñiga-Pflücker, Tak W. Mak; Survivin Loss in Thymocytes Triggers p53-mediated Growth Arrest and p53-independent Cell Death . J Exp Med 2 February 2004; 199 (3): 399–410. doi: https://doi.org/10.1084/jem.20032092
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement